COV.V (COV.V) News
Follow COV.V (COV.V) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Covalon reports real — world analysis shows collagen dressing leads granulation odds in diabetic foot ulcers
Covalon Technologies announced results from a retrospective real-world evidence analysis comparing its collagen matrix dressing with rival collagen dressings. Findings were presented with this announcement, based on de-i
NEWS | Sep 24, 2026, 11:01 AM UTC
L
Covalon real — world analysis shows collagen dressing leads in diabetic foot ulcer granulation odds at 8, 12 weeks
Covalon published a retrospective real-world evidence analysis comparing collagen wound dressings using US Wound Registry data. Bayesian ordinal modeling estimated odds of reaching over 50% granulation coverage at 4, 8,
NEWS | Sep 24, 2026, 11:01 AM UTC